SMS PHARMACEUTICALS
Back to Income Statement
|
SMS PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹102 Cr | ₹69 Cr | ₹50 Cr | ₹-7.06 Cr | ₹62 Cr |
What is the latest Consolidated Net Profit of SMS PHARMACEUTICALS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹102 Cr |
| Mar2025 | ₹69 Cr |
| Mar2024 | ₹50 Cr |
| Mar2023 | ₹-7.06 Cr |
| Mar2022 | ₹62 Cr |
How is Consolidated Net Profit of SMS PHARMACEUTICALS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹102 Cr | 47.52 | |
| Mar2025 | ₹69 Cr | 38.75 | |
| Mar2024 | ₹50 Cr | Positive | |
| Mar2023 | ₹-7.06 Cr | Negative | |
| Mar2022 | ₹62 Cr | - | |
Compare Consolidated Net Profit of peers of SMS PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SMS PHARMACEUTICALS | ₹4,150.4 Cr | -1.6% | 14.8% | 33.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | 0.1% | -0.6% | 15.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | -0.6% | 8.7% | 53% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -0.8% | -1.7% | 34.7% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | -0.6% | -4.2% | -12.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 2.7% | -0.7% | -12.1% | Stock Analytics | |
SMS PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SMS PHARMACEUTICALS | -1.6% |
14.8% |
33.8% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses